Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias
Mary Rios
Clinical cancer research : an official journal of the American Association for Cancer Research, 2003
View PDFchevron_right
Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients
Melisa Stricherz
Biology of Blood and Marrow Transplantation, 2017
View PDFchevron_right
Results of a pharmacokinetic (PK) study of ifosfamide (IFX) in children. High value of age
Nicole Delepine
European Journal of Cancer, 1993
View PDFchevron_right
Applied Clinical Pharmacokinetics
Brian Byrd
View PDFchevron_right
Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years
Michael Spino
British Journal of Clinical Pharmacology, 2016
View PDFchevron_right
Population pharmacokinetics of gentamicin in patients with cancer
Benito Garcia
British Journal of Clinical Pharmacology, 2002
View PDFchevron_right
Drug administration and blood sampling for pharmacokinetic studies in pediatric cancer patients
Carina Ritzmo
2009
View PDFchevron_right
Pharmacokinetics of 2-chloro-2′-deoxyadenosine administered subcutaneously or by continuous intravenous infusion
Bernhard Lauterburg
Cancer Chemotherapy and Pharmacology, 2000
View PDFchevron_right
PHARMACOKINETICS- CLINICAL PHARMACOLOGY
magendira mani vinayagam
View PDFchevron_right
Developmental Pharmacokinetics: Drug Disposition Relative to Age
Michelle Bestic
2014
View PDFchevron_right
Dosing in children
Nick Holford
Clinical Pharmacology and Therapeutics, 2010
View PDFchevron_right
Overview of Clinical Pharmacokinetics in Pediatrics: Possible Implications in Therapy
Herbert Obu
Biomedical & Pharmacology Journal, 2014
View PDFchevron_right
Pharmacokinetics : Interactions of New Drugs and the Human Body
Barry Bleidt
Drugs and the Pharmaceutical Sciences, 1996
View PDFchevron_right
Clinical Pharmacokinetics
DAVID VASQUEZ
View PDFchevron_right
Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer
Joseph Sinkule
Cancer Chemotherapy and Pharmacology, 1982
View PDFchevron_right
Population pharmacokinetics and optimal design of paediatric studies for famciclovir
Michael Looby
British Journal of Clinical Pharmacology, 2009
View PDFchevron_right
Pharmacokinetics of cyclophosphamide and its metabolites in pediatric patients receiving high-dose myeloablative therapy
MICHAEL COLE
2011
View PDFchevron_right
Evaluation of Child/Adult Pharmacokinetic Differences from a Database Derived from the Therapeutic Drug Literature
Dale Hattis, Rob Goble
Toxicological Sciences, 2002
View PDFchevron_right
Newborns, Older Children, and Adults Comparisons of Pharmacokinetics and Pharmacokinetic Variability
Rob Goble
View PDFchevron_right
Population pharmacokinetics of ethambutol in African children: a pooled analysis
Chishala Chabala
Journal of Antimicrobial Chemotherapy, 2022
View PDFchevron_right
Practical Anticipation of Human Efficacious Doses and Pharmacokinetics Using Preclinical In Vitro and in Vivo Data
Handan He
Integrative Approaches in Drug Discovery and Development, 2014
View PDFchevron_right
Effect of reducing the paediatric stavudine dose by half: A physiologically-based pharmacokinetic model
Steve Innes
International Journal of Antimicrobial Agents, 2015
View PDFchevron_right
Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling
francois bouzom
Fundamental & Clinical Pharmacology, 2008
View PDFchevron_right
Variability of 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute leukemia
Pierre Lafolie
Medical oncology and tumor pharmacotherapy, 1989
View PDFchevron_right
Hepatic drug clearance in children with leukemia: Changes in clearance of model substrates during remission-induction therapy
W. Evans, John Pieper
Clinical Pharmacology and Therapeutics, 1987
View PDFchevron_right
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia
Michael Savona
American Journal of Hematology, 2009
View PDFchevron_right
Cyclophosphamide pharmacokinetics in children
MICHAEL COLE
British Journal of Clinical Pharmacology, 1996
View PDFchevron_right
A pharmacokinetic standard for babies and adults
Nick Holford
Journal of Pharmaceutical Sciences, 2013
View PDFchevron_right
General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children
Anna-Karin Hamberg
British Journal of Clinical Pharmacology
View PDFchevron_right
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
Michael Borowitz
Blood, 2011
View PDFchevron_right
Population pharmacokinetics of amphotericin B in children with malignant diseases: Population pharmacokinetics of amphotericin B
Christa Nath
British Journal of Clinical Pharmacology, 2002
View PDFchevron_right
Population pharmacokinetics of liposomal daunorubicin in children
Dirk Reinhardt
British Journal of Clinical Pharmacology, 2003
View PDFchevron_right
A Pharmacokinetic and Pharmacodynamic Review
Carol Vetterly
Critical Care of Children with Heart Disease, 2009
View PDFchevron_right